Status:
COMPLETED
Cold Plasma to Treat Hair Loss
Lead Sponsor:
Dr. Peter C. Friedman
Conditions:
Androgenetic Alopecia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Self applied cold plasma activated medium used for androgenetic alopecia
Eligibility Criteria
Inclusion
- diagnosis of mild-to moderate androgenetic alopecia
- ability of applying treatment regularly
- ability to keep in-person follow-up appointments
Exclusion
- any inflammatory scalp condition
- starting or discontinuing any hair loss treatments within 6 months of start date
- allergy to any components of the carrier solution
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04379752
Start Date
July 1 2020
End Date
September 15 2021
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Skin Center Dermatology Group
New City, New York, United States, 10956